Cargando…
Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340591/ https://www.ncbi.nlm.nih.gov/pubmed/32650019 http://dx.doi.org/10.1016/j.kint.2020.06.025 |
| _version_ | 1783555061089042432 |
|---|---|
| author | Gade, Akhil R. Alavala, Harshitha Allam, Sridhar R. |
| author_facet | Gade, Akhil R. Alavala, Harshitha Allam, Sridhar R. |
| author_sort | Gade, Akhil R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7340591 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | International Society of Nephrology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73405912020-07-08 Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19 Gade, Akhil R. Alavala, Harshitha Allam, Sridhar R. Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2020-10 2020-07-08 /pmc/articles/PMC7340591/ /pubmed/32650019 http://dx.doi.org/10.1016/j.kint.2020.06.025 Text en © 2020 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Gade, Akhil R. Alavala, Harshitha Allam, Sridhar R. Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19 |
| title | Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19 |
| title_full | Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19 |
| title_fullStr | Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19 |
| title_full_unstemmed | Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19 |
| title_short | Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19 |
| title_sort | interleukin 6 levels after tocilizumab administration in transplant recipients with covid-19 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340591/ https://www.ncbi.nlm.nih.gov/pubmed/32650019 http://dx.doi.org/10.1016/j.kint.2020.06.025 |
| work_keys_str_mv | AT gadeakhilr interleukin6levelsaftertocilizumabadministrationintransplantrecipientswithcovid19 AT alavalaharshitha interleukin6levelsaftertocilizumabadministrationintransplantrecipientswithcovid19 AT allamsridharr interleukin6levelsaftertocilizumabadministrationintransplantrecipientswithcovid19 |